Go Back
Samsara BioCapital
Samsara BioCapital, a venture fund based in Palo Alto, California, was founded in 2016. The fund, led by Partner Cory Freedland, focuses on investments in BioTech, Medical Device, Pharmaceuticals, Healthcare, and Life Science sectors. Samsara BioCapital has made 91 investments in companies like Mineralys Therapeutics, Alamar Biosciences, and A2 Biotherapeutics, with 33 successful exits. They provide investment advisory services for startups at various stages from Pre-Seed to Series D. For more information, visit their website at www.samsaracap.com.
About
About
About
Bio
Samsara Biocapital, LLC provides investment advisory services.
Location
Palo Alto, California
Stage
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Partner name
Cory Freedland
Bio
Samsara Biocapital, LLC provides investment advisory services.
Location
Palo Alto, California
Stage
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Partner name
Cory Freedland
Fund
Fund
Fund
Fund Focus
BioTech, Medical Device, Pharmaceuticals, Healthcare, Life Science
Number of investments
91
Number of exits
33
Fund Type
Venture Fund
Portfolio Companies
Mineralys Therapeutics, Alamar Biosciences, Abata Therapeutics, Ionpath, Synthekine, A2 Biotherapeutics
Samsara BioCapital
Samsara BioCapital, a venture fund based in Palo Alto, California, was founded in 2016. The fund, led by Partner Cory Freedland, focuses on investments in BioTech, Medical Device, Pharmaceuticals, Healthcare, and Life Science sectors. Samsara BioCapital has made 91 investments in companies like Mineralys Therapeutics, Alamar Biosciences, and A2 Biotherapeutics, with 33 successful exits. They provide investment advisory services for startups at various stages from Pre-Seed to Series D. For more information, visit their website at www.samsaracap.com.
About
Bio
Samsara Biocapital, LLC provides investment advisory services.
Location
Palo Alto, California
Stage
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Partner name
Cory Freedland
Fund
Fund Focus
BioTech, Medical Device, Pharmaceuticals, Healthcare, Life Science
Number of investments
91
Number of exits
33
Fund Type
Venture Fund
Portfolio Companies
Mineralys Therapeutics, Alamar Biosciences, Abata Therapeutics, Ionpath, Synthekine, A2 Biotherapeutics